Pralatrexate is a DHFR inhibitor for peripheral T-cell Lymphoma Research
Peripheral T-cell lymphomas (PTCL) are malignancies derived from mature (post-thymic) T cells and natural killer cells. As a rare and aggressive type of non-Hodgkin’s lymphoma, PTCL affects mature T cells.…